samedan logo
 
 
spacer
home > ict > spring 2017 > turn of phrase
PUBLICATIONS
International Clinical Trials

Turn of Phrase

Over the past 10 years, the market value of the global pharmaceutical industry has more than doubled to $951 billion. In 2015, markets outside the US and Western Europe accounted for $362 billion, comprising approximately 38% of the total worldwide value (1).

There is no doubt about it: the healthcare industry has become truly global, and clinical trials are being delocalised to match. In fact, between 2005 and 2012, the largest annual growth in clinical trials occurred in Asian (30%) and Latin American/Caribbean (12%) regions (2).

As the clinical trials industry expands into emerging countries, protocols developed in one country are increasingly implemented in culturally and linguistically different locations. Competent and compliant translation is, therefore, becoming more necessary than ever in order to ensure that clinical trial protocols (CPTs) are correctly followed, and that participants can confidently understand and consent to them.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Alicia Lewis is a Brighton-based Writer and Content Specialist for full-service clinical trials agency MD Group. On the company’s website, she comments on the latest biotechnological innovations and creates guides to patientcentric clinical trial protocols. Since 2014, Alicia has been writing content for businesses in the UK and abroad, specialising in healthcare, business, travel and culture.
spacer
Alicia Lewis
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Wickham Laboratories will be on Stand 8 at the 24th Annual Pharmig Conference in the Nottingham Belfry Hotel, November 16th & 17th


More info >>

White Papers

Value-Added Processing and Quality By Design Principles Help Meet High-Quality Demands

West Pharmaceutical Services, Inc.

The current pharmaceutical market has faced a variety of challenges, including increasing expectations for quality from end-users and regulatory agencies driven by concern for patient safety. While pharmaceutical companies are working to assure that new quality and compliance paradigms are met, a balance must be achieved between the reality of managing costs in an effort to provide a product that meets the requirements of payers along with facilitating profitability in order to continue adequate business reinvestment.
More info >>

 
Industry Events

3D Cell Culture 2018

21-22 February 2018, Holiday Inn Kensington Forum, London UK

Building on the sell-out success of the launch event, SMi Group is delighted to announce the return of 3D Cell Culture, taking place on 21st and 22nd of February 2018, in London UK.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement